Empirical Asset Management’s Gilead Sciences GILD Stock Holding History

Empirical Asset Management’s Portfolio GILD Stock Details GILD Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$1.74M	Buy	13,735 +2,551	+23%	+$336K	0.39%	70
2026 Q1	$1.56M	Sell	11,184 -603	-5%	-$84.4K	0.41%	58
2025 Q4	$1.45M	Buy	11,787 +3,279	+39%	+$398K	0.41%	64
2025 Q3	$944K	Sell	8,508 -662	-7%	-$75.2K	0.26%	101
2025 Q2	$1.02M	Buy	9,170 +1,882	+26%	+$200K	0.31%	85
2025 Q1	$817K	Buy	7,288 +240	+3%	+$24.8K	0.28%	97
2024 Q4	$651K	Hold	7,048	–	–	0.22%	132
2024 Q3	$591K	Hold	7,048	–	–	0.21%	146
2024 Q2	$484K	Sell	7,048 -10,129	-59%	-$676K	0.18%	164
2024 Q1	$1.26M	Buy	17,177 +3,581	+26%	+$275K	0.61%	39
2023 Q4	$1.1M	Sell	13,596 -8,747	-39%	-$681K	0.9%	28
2023 Q3	$1.67M	Buy	22,343 +799	+4%	+$61.5K	1.46%	9
2023 Q2	$1.66M	Buy	21,544 +537	+3%	+$42.8K	1.47%	11
2023 Q1	$1.74M	Buy	21,007 +7,412	+55%	+$614K	1.67%	9
2022 Q4	$1.17M	Sell	13,595 -9,201	-40%	-$729K	1.23%	16
2022 Q3	$1.41M	Buy	22,796 +8,679	+61%	+$547K	1.53%	11
2022 Q2	$873K	Buy	14,117 +524	+4%	+$32.4K	0.92%	29
2022 Q1	$808K	Buy	+13,593	New	+$869K	0.77%	42

Other funds holding GILD

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Capital World Investors Los Angeles, California $846B AUM 46.74% 1-Year Est. Return

Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return

Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Empirical Asset Management's GILD Position: Q2 2026 in Review

Empirical Asset Management increased its Gilead Sciences (GILD) stake by 23% in Q2 2026, buying an estimated $336K and bringing the position to 13,735 shares worth $1.74M. The position accounts for 0.39% of the portfolio, ranked #70.

Empirical Asset Management first reported a position in GILD in Q1 2022 and has held it in 18 quarters since. The position peaked at $1.74M in Q1 2023. 2,278 funds tracked by Wall St. Rank hold GILD as of Q2 2026.

Empirical Asset Management held 13,735 shares of Gilead Sciences worth $1.74M as of Q2 2026.
Empirical Asset Management bought 2,551 Gilead Sciences shares in Q2 2026, an estimated $336K.
Gilead Sciences made up 0.39% of Empirical Asset Management's portfolio in Q2 2026, its #70 holding.
Empirical Asset Management first reported a position in Gilead Sciences in Q1 2022 and has held it in 18 quarters since.
Empirical Asset Management's Gilead Sciences position peaked at $1.74M in Q1 2023.
2,278 funds tracked by Wall St. Rank held Gilead Sciences as of Q2 2026.

Based on Empirical Asset Management's 13F filing for Q2 2026, filed 10 Aug 2026.